This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Registration of Medicines in the Soviet Control and Licensing System on the Example of the Cardiological Drug Trinitrolong, Rational Pharmacotherapy in Cardiology, March 2021, Stolichnaya Izdatelskaya Kompaniyaizdat,
DOI: 10.20996/1819-6446-2021-02-06.
You can read the full text:
The following have contributed to this page
